Skip to main content

Breadcrumb

  1. Home

Submission Tool and Repository Measure Database

As the Centers for Medicare & Medicaid Services (CMS) consensus-based entity (CBE), Battelle Memorial Institute (Battelle) discloses complete information (e.g., full measure specifications, coding logic, algorithms) regarding each measure to the public for the purpose of evaluating, analyzing, or displaying of each measure for endorsement consideration. If an interested party wishes to attain complete measure information for the use and/or implementation of a measure, the interested party should contact the measure steward. Contact information for the measure steward can be found under the “Point of Contact” section of the respective measure page within the Submission Tool and Repository (STAR). Battelle is not responsible for, nor is privy to the measure use agreements that may be established between a measure steward and an interested party.

To obtain a copy of the full measure submission forms for measures endorsed prior to Fall 2022 cycle, please contact [email protected].

No Filters Selected
          CBE ID Sort descending Title Steward Endorsement Cycle Status Date of Last Endorsement Decision
          0389e Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients Centers for Medicare & Medicaid Services Endorsement Removed
          0390 Prostate Cancer: Combination Androgen Deprivation Therapy for High Risk or Very High Risk Prostate Cancer American Urological Association Endorsement Removed
          0391 Breast Cancer Resection Pathology Reporting- pT category (primary tumor) and pN category (regional lymph nodes) with histologic grade College of American Pathologists Endorsement Removed
          0392 Colorectal Cancer Resection Pathology Reporting- pT category (primary tumor) and pN category (regional lymph nodes) with histologic grade College of American Pathologists Endorsement Removed
          0393 Hepatitis C: Confirmation of Hepatitis C Viremia American Gastroenterological Association Endorsement Removed
          0394 Hepatitis C: Counseling Regarding Use of Contraception Prior to Antiviral Treatment Physician Consortium for Performance Improvement Endorsement Removed
          0395 Paired Measure: Hepatitis C Ribonucleic Acid (RNA) Testing Before Initiating Treatment (paired with 0396) American Gastroenterological Association Endorsement Removed
          0396 Paired Measure: Hepatitis C Virus (HCV) Genotype Testing Prior to Treatment (paired with 0395) American Gastroenterological Association Endorsement Removed
          0397 Hepatitis C: Antiviral Treatment Prescribed Physician Consortium for Performance Improvement Endorsement Removed
          0398 Hepatitis C: Hepatitis C Virus (HCV) Ribonucleic Acid (RNA) Testing Between 4-12 Weeks after Initiation of Treatment American Gastroenterological Association Endorsement Removed